The outcome of anticoagulation alone therapy for patients with submassive pulmonary embolism Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism Year: 2019
Influence of cancer diagnosis in patients with pulmonary embolism Source: Virtual Congress 2020 – Pulmonary embolism Year: 2020
Complications of anticoagulant therapy in patients with pulmonary thromboembolism Source: Eur Respir J 2007; 30: Suppl. 51, 604s Year: 2007
Recurrence and bleeding in the extended treatment of patients with pulmonary embolism (PE) and cancer Source: International Congress 2018 – Diagnosis, prognostication and treatment of pulmonary embolism Year: 2018
Clinical characteristics and outcomes of patients with clinically unsuspected pulmonary embolism versus patients with clinically suspected pulmonary embolism Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012
Clinical profile and mortality of patients with pulmonary embolism and cancer Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots Year: 2015
Clinical usefulness of D-dimer in cancer patients with suspected pulmonary embolism Source: Eur Respir J 2003; 22: Suppl. 45, 220s Year: 2003
Risk factors for recurrences in patients with idiopathic pulmonary embolism after withdrawal of long-term anticoagulation Source: Eur Respir J 2006; 28: Suppl. 50, 44s Year: 2006
Effect of statin therapy in patients with lung cancer on mortality, incidence of infections and pulmonary embolism Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012
Clinical features and short-term outcomes of cancer patients with suspected and unsuspected pulmonary embolism: the EPIPHANY study Source: Eur Respir J 2017; 49(1): 1600282; DOI: 10.1183/13993003.00282-2016 Year: 2017
Thrombolytic therapy in cases with massive pulmonary thromboembolism Source: Eur Respir J 2005; 26: Suppl. 49, 521s Year: 2005
Frequency of chronic thromboembolic pulmonary hypertension screening after pulmonary embolism in cancer patients. Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies Year: 2018
Safety of withholding anticoagulant therapy in patients who have clinically suspected pulmonary embolism and negative results on helical CT Source: Eur Respir J 2003; 22: Suppl. 45, 218s Year: 2003
Evolution of CT findings after anticoagulant treatment for acute pulmonary embolism in patients with and without an ultimate diagnosis of chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 58 (6) 2100699; 10.1183/13993003.00699-2021 Year: 2021
Incidental lung malignancies detected by CTPA in patients with suspected pulmonary embolism are not associated with better survival outcomes Source: Annual Congress 2010 - Vascular and solitary lesions Year: 2010
Direct oral anticoagulant use and thrombus detection in patients with chronic thromboembolic pulmonary hypertension referred for pulmonary thromboendarterectomy Source: International Congress 2019 – Chronic thromboembolic pulmonary hypertension Year: 2019
Mortality and recurrence during a follow-up of 2 years of pulmonary embolism: Role of anticoagulant therapy Source: Annual Congress 2010 - Pulmonary embolism Year: 2010
Perioperative pulmonary complications and management of patients with COPD and esophageal malignancy Source: Annual Congress 2011 - COPD management Year: 2011
Direct oral anticoagulant therapy in patients with morbid obesity after intermediate- or high-risk pulmonary emboli Source: ERJ Open Res, 7 (1) 00554-2020; 10.1183/23120541.00554-2020 Year: 2021
Prognostic value of the ECG on admission in patients with acute major pulmonary embolism Source: Eur Respir J 2005; 25: 843-848 Year: 2005